Calamos Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,705
| Closed | -$1.95M | – | 969 |
|
|
2023
Q4 | $1.95M | Sell |
15,705
-9,942
| -39% | -$1.23M | 0.01% | 574 |
|
|
2023
Q3 | $2.98M | Buy |
25,647
+5,036
| +24% | +$584K | 0.02% | 554 |
|
|
2023
Q2 | $2.42M | Buy |
20,611
+9,090
| +79% | +$1.07M | 0.01% | 617 |
|
|
2023
Q1 | $922K | Buy |
+11,521
| New | +$922K | ﹤0.01% | 796 |
|